FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ganesh Palapattu

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Disease Progression

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Abhinav Khanna; Stuart Lipsitz; Paul L Nguyen; Xiangmei Gu; Jim C Hu; Ganesh S Palapattu
Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
William D Ulmer; Toni K Choueiri; Christopher Dodgion; Xiangmei Gu; Keith J Kowalczyk; Stuart Lipsitz; Ganesh S Palapattu; Sandip M Prasad; Jim C Hu
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States.
Jichao Qin; Mahipal V Suraneni; Tammy Calhoun-Davis; Xin Chen; Grace Choy; Jiaoti Huang; Ivan Ivanov; Collene R Jeter; Brian Laffin; Hangwen Li; Wei Li; Kevin Lin; Xin Liu; Ganesh S Palapattu; Shen Pang; Dean G Tang
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ganesh Palapattu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Abhinav Khanna; Stuart Lipsitz; Paul L Nguyen; Xiangmei Gu; Jim C Hu; Ganesh S Palapattu
Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
The Journal of urology 2013;189(1):75-9.
2012: William D Ulmer; Toni K Choueiri; Christopher Dodgion; Xiangmei Gu; Keith J Kowalczyk; Stuart Lipsitz; Ganesh S Palapattu; Sandip M Prasad; Jim C Hu
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States.
The Journal of urology 2012;188(3):775-80.
2012: Jichao Qin; Mahipal V Suraneni; Tammy Calhoun-Davis; Xin Chen; Grace Choy; Jiaoti Huang; Ivan Ivanov; Collene R Jeter; Brian Laffin; Hangwen Li; Wei Li; Kevin Lin; Xin Liu; Ganesh S Palapattu; Shen Pang; Dean G Tang
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
Cell stem cell 2012;10(5):556-69.
2011: Nagireddy Putluri; Vasanta Putluri; Theodore R Sana; Shahrokh F Shariat; Huidong Shi; Ali Shojaie; Gabriel Sica; Daniel J Brat; Charles Butler; Steven M Fischer; Yair Lotan; George Michailidis; Srilatha Nalluri; Ganesh S Palapattu; Katrin Panzitt; Christopher T Tallman; Martha K Terris; Gagan Singh Thangjam; Shaiju K Vareed; Vihas T Vasu; Alon Z Weizer; Arun Sreekumar
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Cancer research 2011;71(24):7376-86.
2011: Nagireddy Putluri; Vasanta Putluri; Theodore R Sana; Ali Shojaie; Jeman Byun; Chad J Creighton; Steven M Fischer; George Michailidis; Srilatha Nalluri; Ganesh S Palapattu; Subramaniam Pennathur; Shaiju K Vareed; Vihas T Vasu; Anuradha Vivekanandan-Giri; Arun Sreekumar
Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
PloS one 2011;6(7):e21417.
2011: Liang Gao; Haijun Zhou; Michael J Thrall; Fuhai Li; Yaliang Yang; Zhiyong Wang; Pengfei Luo; Kelvin K Wong; Ganesh S Palapattu; Stephen Wong
Label-free high-resolution imaging of prostate glands and cavernous nerves using coherent anti-Stokes Raman scattering microscopy.
Biomedical optics express 2011;2(4):915-26.
2010: Christopher R Silvers; Karin Williams; Linda Salamone; Jiaoti Huang; Craig T Jordan; Haijun Zhou; Ganesh S Palapattu
A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors.
The Prostate 2010;70(13):1379-87.
2010: David J Mener; Angelo Cambio; David G Stoddard; Brad A Martin; Ganesh S Palapattu
The impact of HMG-CoA reductase therapy on serum PSA.
The Prostate 2010;70(6):608-15.
2010: Guru Sonpavde; Ganesh S Palapattu
Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.
Expert review of anticancer therapy 2010;10(3):439-50.
2010: Michaella M Prasad; Sandip M Prasad; Nathanael D Hevelone; Xiangmei Gu; Aaron C Weinberg; Stuart R Lipsitz; Ganesh S Palapattu; Jim C Hu
Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer.
The journal of sexual medicine 2010;7(3):1062-73.
2010: Ganesh S Palapattu; Eric A Singer; Edward M Messing
Controversies surrounding lymph node dissection for prostate cancer.
The Urologic clinics of North America 2010;37(1):57-65, Table of Contents.
2009: Hendrik Isbarn; Pierre I Karakiewicz; Shahrokh F Shariat; umberto capitanio; Ganesh S Palapattu; Arthur I Sagalowsky; Yair Lotan; Mark P Schoenberg; Gilad E Amiel; Seth P Lerner; Guru Sonpavde
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
The Journal of urology 2009;182(2):459-65; discussion 465.
2009: Ganesh S Palapattu; Chengyu Wu; Christopher R Silvers; Heather B Martin; Karin Williams; Linda Salamone; Timothy Bushnell; Li-Shan Huang; Qi Yang; Jiaoti Huang
Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
The Prostate 2009;69(7):787-98.
2009: umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Yair Lotan; Ganesh S Palapattu; Patrick J Bastian; Amit Gupta; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Pierre I Karakiewicz
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.
BJU international 2009;103(10):1359-62.
2009: Rochelle A Simon; P Anthony di Sant'Agnese; Li-Shan Huang; Haodong Xu; Jorge L Yao; Qi Yang; Sharon Liang; Jinsong Liu; Rena Yu; Liang Cheng; William K Oh; Ganesh S Palapattu; Jianjun Wei; Jiaoti Huang
CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
Human pathology 2009;40(2):252-8.
2008: THOMAS GUZZO; Craig G Rogers; Chris Y Deng; Trinity J Bivalacqua; Ganesh S Palapattu; Patrick J Bastian; Mario A Eisenberger; Mark P Schoenberg; Mark L Gonzalgo
Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease.
BJU international 2008;102(11):1539-43.
2008: Eric A Singer; Ganesh S Palapattu; Edwin van Wijngaarden
Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey.
Cancer 2008;113(8):2053-7.
2008: Dragan Golijanin; Ganesh S Palapattu
Editorial comment on: bladder and urethral sphincter function after radical retropubic prostatectomy: a prospective long-term study.
European urology 2008;54(3):664.
2008: Jochen Walz; Shahrokh F Shariat; Nazareno Suardi; Paul Perrotte; Yair Lotan; Ganesh S Palapattu; Amit Gupta; Patrick J Bastian; Craig G Rogers; Amnon Vazina; Gilad E Amiel; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner; Pierre I Karakiewicz
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
BJU international 2008;101(11):1356-61.
2008: Amit Gupta; Yair Lotan; Patrick J Bastian; Ganesh S Palapattu; Pierre I Karakiewicz; Ganesh V Raj; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Shahrokh F Shariat
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Urology 2008;71(2):302-7.
2008: Patrick J Bastian; Ganesh S Palapattu; Srinivasan Yegnasubramanian; Craig G Rogers; Xiaohui Lin; Leslie A Mangold; Bruce J Trock; Mario A Eisenberger; Alan W Partin; William G Nelson
CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.
The Journal of urology 2008;179(2):529-34; discussion 534-5.
2008: Edwin van Wijngaarden; Eric A Singer; Ganesh S Palapattu
Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey.
The Prostate 2008;68(2):122-8.
2008: Patrick J Bastian; Georg C Hutterer; Shahrokh F Shariat; Craig G Rogers; Ganesh S Palapattu; Yair Lotan; Amnon Vazina; Gilad E Amiel; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg; Pierre I Karakiewicz
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
BJU international 2008;101(4):450-4.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Seth P Lerner; Ganesh S Palapattu; Richard J Cote; Arthur I Sagalowsky; Yair Lotan
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
Cancer 2008;112(2):315-25.
2008: Rochelle A Simon; P Anthony di Sant'Agnese; Ganesh S Palapattu; Eric A Singer; Grace D Candelario; Jiaoti Huang; Jorge L Yao
Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation.
International journal of clinical and experimental pathology 2008;1(2):180-4.
2007: Matthew Nielsen; Patrick J Bastian; Ganesh S Palapattu; Bruce J Trock; Mark P Schoenberg; Theresa Y Chan; Craig G Rogers
Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
Urology 2007;70(6):1091-5.
2007: Matthew Nielsen; Ganesh S Palapattu; Pierre I Karakiewicz; Yair Lotan; Patrick J Bastian; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
BJU international 2007;100(5):1015-20.
2007: Patrick J Bastian; Ganesh S Palapattu; Srinivasan Yegnasubramanian; Xiaohui Lin; Craig G Rogers; Leslie A Mangold; Bruce J Trock; Mario A Eisenberger; Alan W Partin; William G Nelson
Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5361-7.
2007: Eric A Singer; David F Penson; Ganesh S Palapattu
PSA screening and elderly men.
JAMA : the journal of the American Medical Association 2007;297(9):949; author reply 949-50.
2007: Matthew Nielsen; Shahrokh F Shariat; Pierre I Karakiewicz; Yair Lotan; Craig G Rogers; Gilad E Amiel; Patrick J Bastian; Amnon Vazina; Amit Gupta; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ganesh S Palapattu
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
European urology 2007;51(3):699-706; discussion 706-8.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
European urology 2007;51(1):152-60.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
European urology 2007;51(1):137-49; discussion 149-51.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
The Journal of urology 2006;176(6 Pt 1):2414-22; discussion 2422.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Paul Perrotte; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Precystectomy nomogram for prediction of advanced bladder cancer stage.
European urology 2006;50(6):1254-60; discussion 1261-2.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Gilad E Amiel; Yair Lotan; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Amit Gupta; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6663-76.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Amiel E Gilad; Yair Lotan; Craig G Rogers; Amnon Vazina; Amit Gupta; Patrick J Bastian; Paul Perrotte; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
The Journal of urology 2006;176(4 Pt 1):1354-61; discussion 1361-2.
2006: Shahrokh F Shariat; Ganesh S Palapattu; Gilad E Amiel; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.
Urology 2006;68(3):538-42.
2006: Ganesh S Palapattu; Alan K Meeker; Timothy Harris; Michael I Collector; Saul J Sharkis; Angelo M DeMarzo; Christopher A Warlick; Charles G Drake; William G Nelson
Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium.
The Journal of urology 2006;176(2):813-8.
2006: Craig G Rogers; Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Yair Lotan; Amit Gupta; Amnon Vazina; Amiel Gilad; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
The Journal of urology 2006;175(6):2048-53; discussion 2053.
2006: Ganesh S Palapattu; Edward M Messing
Do prostate cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?
Nature clinical practice. Urology 2006;3(5):258-9.
2006: Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Yair Lotan; Amnon Vazina; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
The Journal of urology 2006;175(5):1645-9; discussion 1649.
2005: Yair Lotan; Amit Gupta; Shahrokh F Shariat; Ganesh S Palapattu; Amnon Vazina; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Paul Perotte; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6533-9.
2005: Ganesh S Palapattu; Siobhan Sutcliffe; Patrick J Bastian; Elizabeth A Platz; Angelo M DeMarzo; William B Isaacs; William G Nelson
Prostate carcinogenesis and inflammation: emerging insights.
Carcinogenesis 2005;26(7):1170-81.
2005: Patrick J Bastian; Ganesh S Palapattu; Xiaohui Lin; Srinivasan Yegnasubramanian; Leslie A Mangold; Bruce J Trock; Mario A Eisenberger; Alan W Partin; William G Nelson
Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4037-43.
2004: Patrick J Bastian; Srinivasan Yegnasubramanian; Ganesh S Palapattu; Craig G Rogers; Xiaohui Lin; Angelo M DeMarzo; William G Nelson
Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
European urology 2004;46(6):698-708.
2004: Ganesh S Palapattu; Patrick J Bastian; Phillip R Slavney; Mary Ellen Haisfield-Wolfe; Joanne M Walker; Karlynn BrintzenhofeSzoc; Bruce J Trock; James Zabora; Mark P Schoenberg
Preoperative somatic symptoms are associated with disease progression in patients with bladder carcinoma after cystectomy.
Cancer 2004;101(10):2209-13.
2004: Ganesh S Palapattu; Mohamad E Allaf; Bruce J Trock; Jonathan I Epstein; Patrick C Walsh
Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
The Journal of urology 2004;172(5 Pt 1):1860-4.
2004: Mohamad E Allaf; Ganesh S Palapattu; Bruce J Trock; H Ballentine Carter; Patrick C Walsh
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.
The Journal of urology 2004;172(5 Pt 1):1840-4.
2004: Ganesh S Palapattu; Mary Ellen Haisfield-Wolfe; Joanne M Walker; Karlynn BrintzenhofeSzoc; Bruce J Trock; James Zabora; Mark P Schoenberg
Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer.
The Journal of urology 2004;172(5 Pt 1):1814-7.
2004: Ganesh S Palapattu; David A Bloom; Robert B Smith; Richard Boxer
Willard E. Goodwin: educator, innovator and pioneer.
The Journal of urology 2004;172(1):40-4.
2003: Ganesh S Palapattu; Allan J Pantuck; Frederick Dorey; Jonathan W Said; Robert A Figlin; Arie S Belldegrun
Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies.
The Journal of urology 2003;170(3):768-72; discussion 772.
2003: Ganesh S Palapattu; Hyung L Kim; Arie S Belldegrun
Advances in the Treatment of Genitourinary Cancer: Highlights from the 3rd Annual Meeting of the Society of Urologic Oncology, December 13-14, 2002, Washington, DC.
Reviews in urology 2003;5(4):232-4.
2003: Ganesh S Palapattu; Hyung L Kim; Arie S Belldegrun
Lymph node dissection in patients with kidney cancer: when is it indicated?
Reviews in urology 2003;5(3):196-9.
2002: Ganesh S Palapattu; Robert E Reiter
Monoclonal antibody therapy for genitourinary oncology: promise for the future.
The Journal of urology 2002;168(6):2615-23.
2002: Ganesh S Palapattu; Blaine Kristo; Jacob Rajfer
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.
Reviews in urology 2002;4(4):163-70.
2001: Ganesh S Palapattu; ZL Barbaric; Jacob Rajfer
Acute bilateral renal cortical necrosis as a cause of postoperative renal failure.
Urology 2001;58(2):281.
2001: N Amara; Ganesh S Palapattu; Matthew Schrage; Z Gu; George V Thomas; F Dorey; Jonathan Said; Robert E Reiter
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Cancer research 2001;61(12):4660-5.
1999: Ganesh S Palapattu; J Naitoh; Arie S Belldegrun
Gene therapy for prostate cancer. New perspectives on an old problem.
The Urologic clinics of North America 1999;26(2):353-63, ix.